• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾素-血管紧张素系统与动脉粥样硬化血栓形成性疾病:从基因到治疗

Renin-angiotensin system and atherothrombotic disease: from genes to treatment.

作者信息

Jacoby Douglas S, Rader Daniel J

机构信息

Division of Cardiovascular Medicine, Department of Medicine, University of Pennsylvania Health System, 3400 Spruce Street, Philadelphia, PA 19104, USA.

出版信息

Arch Intern Med. 2003 May 26;163(10):1155-64. doi: 10.1001/archinte.163.10.1155.

DOI:10.1001/archinte.163.10.1155
PMID:12767951
Abstract

The renin-angiotensin system plays a central role in the pathogenesis of cardiovascular disease. At the molecular and cellular levels, angiotensin II, the main effector peptide of the system, stimulates key components of atherosclerosis. Trials in animals and humans indicate that blocking renin-angiotensin system pathways decreases atherosclerotic plaque progression and ischemic events. This review provides a broad overview of the entire role of the renin-angiotensin system in atherothrombotic disease, ranging from molecular pathways to human genetics to the latest clinical trials.

摘要

肾素-血管紧张素系统在心血管疾病的发病机制中起核心作用。在分子和细胞水平上,该系统的主要效应肽血管紧张素II会刺激动脉粥样硬化的关键成分。动物和人体试验表明,阻断肾素-血管紧张素系统途径可减少动脉粥样硬化斑块进展和缺血事件。本综述全面概述了肾素-血管紧张素系统在动脉粥样硬化血栓形成疾病中的整体作用,涵盖从分子途径到人类遗传学再到最新临床试验的各个方面。

相似文献

1
Renin-angiotensin system and atherothrombotic disease: from genes to treatment.肾素-血管紧张素系统与动脉粥样硬化血栓形成性疾病:从基因到治疗
Arch Intern Med. 2003 May 26;163(10):1155-64. doi: 10.1001/archinte.163.10.1155.
2
Renin angiotensin system and ASCVD.
Curr Opin Cardiol. 2000 May;15(3):141-50. doi: 10.1097/00001573-200005000-00004.
3
[Atherosclerosis and arteriitis: implications for therapy of cardiovascular disease].[动脉粥样硬化与动脉炎:对心血管疾病治疗的影响]
Herz. 2004 Feb;29(1):4-11. doi: 10.1007/s00059-004-2520-5.
4
The role of endothelium in antithrombotic effect of the renin-angiotensin system blockade.
J Physiol Pharmacol. 1999 Dec;50(4):499-507.
5
[Anti-atherosclerotic action of ACE inhibitors. I. Inactivation of the renin-angiotensin system].血管紧张素转换酶抑制剂的抗动脉粥样硬化作用。I. 肾素-血管紧张素系统的失活
Postepy Hig Med Dosw. 1996;50(2):157-71.
6
Fibrinolytic balance, the renin-angiotensin system and atherosclerotic disease.纤溶平衡、肾素-血管紧张素系统与动脉粥样硬化疾病
Eur Heart J. 1998 Jul;19 Suppl G:G9-12.
7
[Atherosclerosis].
Nihon Rinsho. 2005 Mar;63 Suppl 3:161-6.
8
Role of the renin-angiotensin-aldosterone system in vascular remodeling and inflammation: a clinical review.肾素-血管紧张素-醛固酮系统在血管重塑和炎症中的作用:一项临床综述
J Hypertens. 2006 Jun;24(6):983-91. doi: 10.1097/01.hjh.0000226182.60321.69.
9
Endothelial function, fibrinolysis, and angiotensin-converting enzyme inhibition.内皮功能、纤维蛋白溶解与血管紧张素转换酶抑制作用
Clin Cardiol. 1997 Nov;20(11 Suppl 2):II-34-7.
10
The role of the renin-angiotensin system in vascular health: use of ACE inhibition to improve vascular function.肾素-血管紧张素系统在血管健康中的作用:使用血管紧张素转换酶抑制剂改善血管功能。
Heart Dis. 2000 Sep-Oct;2(5):380-3.

引用本文的文献

1
Genetic silencing of K3.1 inhibits atherosclerosis in ApoE null mice.K3.1的基因沉默可抑制载脂蛋白E基因敲除小鼠的动脉粥样硬化。
Channels (Austin). 2025 Dec;19(1):2538864. doi: 10.1080/19336950.2025.2538864. Epub 2025 Aug 3.
2
The vitamin D spectrum: insights into 25(OH)D and VDBP in chronic kidney disease and post-transplant.维生素D谱:对慢性肾脏病及移植后25(OH)D和维生素D结合蛋白的见解
Sci Rep. 2025 May 26;15(1):18395. doi: 10.1038/s41598-025-03035-2.
3
Effect of renin angiotensin system inhibitors on long-term major cardiovascular outcomes in patients with high atherosclerotic cardiovascular risk.
血管紧张素转化酶抑制剂和血管紧张素受体拮抗剂对有高动脉粥样硬化性心血管风险患者的长期主要心血管结局的影响。
Sci Rep. 2023 Dec 27;13(1):23066. doi: 10.1038/s41598-023-50430-8.
4
Unveiling Wide Spectrum Therapeutic Implications and Signaling Mechanisms of Valsartan in Diverse Disorders: A Comprehensive Review.揭示缬沙坦在多种疾病中的广泛治疗意义和信号机制:全面综述。
Curr Drug Res Rev. 2024;16(3):268-288. doi: 10.2174/2589977515666230717120828.
5
Molecular Mimicry of the Viral Spike in the SARS-CoV-2 Vaccine Possibly Triggers Transient Dysregulation of ACE2, Leading to Vascular and Coagulation Dysfunction Similar to SARS-CoV-2 Infection.SARS-CoV-2 疫苗中病毒刺突的分子模拟可能会导致 ACE2 短暂失调,导致类似于 SARS-CoV-2 感染的血管和凝血功能障碍。
Viruses. 2023 Apr 25;15(5):1045. doi: 10.3390/v15051045.
6
An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection.血管紧张素转换酶2的结构/功能、多态性及其在2019冠状病毒病病理生理学中的双重性质的最新进展:对与严重急性呼吸综合征冠状病毒感染相关的血管和凝血疾病的影响。
Front Microbiol. 2022 Nov 28;13:1042200. doi: 10.3389/fmicb.2022.1042200. eCollection 2022.
7
Therapeutic Approaches in COVID-19 Patients: The Role of the Renin-Angiotensin System.治疗 COVID-19 患者的方法:肾素-血管紧张素系统的作用。
Can Respir J. 2022 Sep 26;2022:8698825. doi: 10.1155/2022/8698825. eCollection 2022.
8
Enhancement of EPC migration by high-dose lisinopril is superior compared to captopril and ramipril.高剂量赖诺普利比卡托普利和雷米普利更能增强 EPC 迁移。
F1000Res. 2021 Jan 11;10:15. doi: 10.12688/f1000research.26395.1. eCollection 2021.
9
Human gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection.人类基因多态性及其对 SARS-CoV-2 感染临床结局的可能影响。
Arch Virol. 2021 Aug;166(8):2089-2108. doi: 10.1007/s00705-021-05070-6. Epub 2021 May 2.
10
Angiotensin System Inhibitors May Improve Outcomes of Patients With Castration-Resistant Prostate Cancer During Abiraterone Acetate Treatment-A Cardio-Oncology Study.血管紧张素系统抑制剂可能改善醋酸阿比特龙治疗期间去势抵抗性前列腺癌患者的预后——一项心脏肿瘤学研究
Front Oncol. 2021 Apr 1;11:664741. doi: 10.3389/fonc.2021.664741. eCollection 2021.